A detailed history of Klr Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Klr Investment Advisors, LLC holds 473 shares of LLY stock, worth $372,813. This represents 0.25% of its overall portfolio holdings.

Number of Shares
473
Previous 470 0.64%
Holding current value
$372,813
Previous $274 Million 26.26%
% of portfolio
0.25%
Previous 0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $1,776 - $2,376
3 Added 0.64%
473 $346 Million
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $246,839 - $290,991
470 New
470 $274 Million
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $150,467 - $201,192
429 New
429 $201 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Klr Investment Advisors, LLC Portfolio

Follow Klr Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klr Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klr Investment Advisors, LLC with notifications on news.